Myeloma Patients Europe (MPE) relaunches Myeloma Access Atlas platformAccess, MPE, MyelomaOctober 19, 2021
Open call for members to participate in patient information pilot (deadline Mon 12 February)MPEFebruary 5, 2018
MPE provided feedback on the HTA Implementing Regulation on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union levellatest, MPE, NewsNovember 27, 2024
MPE comments on the European Medicines Agency’s policy on the handling of competing interests of scientific committees’ members and expertsMPE, NewsNovember 14, 2024
WECAN workgroup of patient advocates and industry experts releases guiding principles for reasonable legal agreements between patient advocates and pharmaceutical companiesMPENovember 28, 2018
During European Myeloma Day, MPE highlights the importance of improving access to clinical trialsAccess, MPE, MyelomaSeptember 27, 2024
ASH 2023 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, MPE, MyelomaDecember 15, 2023
